Table 4.

Multivariate analysis results for OS/NRM since enrollment

		OS				NRM
Parameter	Category	p-value	HR	95% HR CI		p-value	HR	95% HR CI
Lower GI	Involved	0.05	1.67	1.01	2.77	0.05	1.84	1.01	3.37
	Not involved		1.00				1.00
Bilirubin	Involved	0.001	2.46	1.48	4.09	0.02	2.15	1.13	4.11
	Not involved		1.00				1.00
Site	FHCRC	0.21	0.77	0.51	1.16	0.34	0.78	0.47	1.30
	Other sites		1.00				1.00
Case type	Incident	0.37	0.80	0.49	1.31	0.62	0.86	0.48	1.56
	Prevalent		1.00				1.00
Time from HCT to enrollment	< 12 months	0.34	1.28	0.77	2.11	0.49	0.81	0.44	1.48
	≥ 12 months		1.00				1.00
Platelet	< 100K	0.03	1.70	1.05	2.78	0.001	2.56	1.45	4.52
	≥ 100K				1.00		1.00
KPS	< 80	0.005	1.87	1.21	2.89	<0.001	2.77	1.59	4.83
	Missing	0.18	1.46	0.84	2.56	0.01	2.48	1.25	4.93
	≥ 80		1.00				1.00
Age at transplant, years	≥ 50	0.72	1.08	0.71	1.66	0.78	0.93	0.55	1.57
	< 50		1.00				1.00
Donor match	Matched unrelated	0.75	1.08	0.68	1.70	0.34	1.32	0.75	2.33
	Mismatched	0.57	1.17	0.68	2.01	0.56	1.22	0.63	2.36
	Matched related		1.00				1.00
Donor/patient gender combination	Female donor male patients	0.73	0.93	0.60	1.43	0.51	0.83	0.48	1.44
	Others		1.00				1.00
Conditioning type	Myeloablative	0.42	0.84	0.55	1.28	0.14	0.68	0.41	1.14
	Non-myeloablative		1.00				1.00
Prior acute GVHD	Yes	0.66	0.91	0.60	1.39	0.57	0.86	0.51	1.45
	No		1.00				1.00